How do pharmaceutical companies perform in compliance?

[market analysis of China Pharmaceutical network] the report funded by the bill and Melinda Gates Foundation has been published since 2008, once every two years The report, released last month, lists 51 compliance related indicators, 31 of which are code of conduct violations and 20 of which are civil or criminal violations CCTV's secret visit to the hospital to expose kickbacks and inflated drug prices caused a thousand waves Let's leave the doctor alone and come to see the medicine How is the compliance performance of pharmaceutical companies? A biennial report released last month provides a rare opportunity for X-ray scanning of pharmaceutical companies The report, produced by the access to medicine foundation and funded by the bill and Melinda Gates Foundation, has been available since 2008 This year's ranking is particularly eye-catching, not only because compliance has gained more attention from pharmaceutical companies, but also because in the current global economic slowdown, saving poor performance has become the top priority from sales executives to pharmaceutical representatives, and compliance is particularly prominent (the overall compliance performance is weak, the report points out) in this year's ranking, what's surprising is that Gilead science is once again in compliance with the regulations of pharmaceutical enterprises This pharmaceutical enterprise famous for selling one thousand yuan of hepatitis C drugs is one of the only two pharmaceutical enterprises without "doing evil", the report points out Evildoing refers to any criminal or civil disputes, corruption or immoral marketing Gilead's high quality system ensures that employees comply with laws, regulations and codes of conduct In particular, the California based company was favored by the report for providing compliance training to third parties such as sales agents and distributors, a pocket guide to ensure that third-party contractors comply with Gilead's guidelines After Gilead and Novo Nordisk, the moral model, are Weicai and Roche However, Gilead, like most other companies, is not transparent about marketing activities, the report said "Two Germany" plus one health (Weicai) and one AI (ebwi) are also four pharmaceutical companies that have not been subject to legal or regulatory sanctions due to corruption or unethical marketing during the reporting period The report lists 51 compliance related indicators, 31 of which are code of conduct violations and 20 of which are civil or criminal violations "In low-income and middle-income (emerging markets) countries, companies may face greater risk of non-compliance These countries may have weak regulatory systems "This highlights the need for companies operating in these markets to implement compliance systems," the report notes (the compliance ranking of the world's largest pharmaceutical companies changes On the left is the 2016 ranking, followed by the 2014 ranking) followed by four in the compliance field by seven companies (ranking 5-11), including Sanofi, Johnson & Johnson and Merck Sanofi's rise was significant, jumping from 13th in the previous report to 5th, mainly due to significant improvements in its compliance system, the report said The French pharmaceutical company conducts annual audits in key markets, as well as rotating audits in other risk sensitive countries Followed by six companies, Lilly, Takeda, Bayer, sankun, Novartis and Bristol Myers Squibb Lilly and Bayer were found to have broken the code of conduct Novartis was found guilty of three violations of corrupt or unethical marketing involving civil law, including one in China and four violations of the code of conduct Bristol Myers Squibb fell sharply from No 3 to No 17 in its compliance ranking, due to violations of civil law anti-corruption regulations in China The report also found that compliance laggards included Estelle, bringer Ingelheim and Pfizer, all of which were subject to civil or criminal penalties during the report's analysis of corrupt or unethical marketing Pfizer is at the bottom of the compliance rankings and found to be in violation of corrupt and unethical marketing laws or regulations, including in China.